Share price movement
Board notes share price increase and confirms no material developments other than recent board changes.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
The Board of Futura Medical plc (AIM: FUM), the consumer healthcare Group behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, notes the recent increase in the Company's share price and, save for board changes and the proposed appointment of Alex Duggan as Interim CEO (subject to completion of due diligence) announced on the 8 July, the board advises that it knows of no reason for this rise.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.